Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Administration of nicotinamide mononucleotide in the treatment of disease

Administration of nicotinamide mononucleotide in the treatment of disease

US Patent 12150950 · Granted Nov 26, 2024

Estimated economic value: $9,695,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods of treatment using nicotinamide mononucleotide2025
GDF15 in glaucoma and methods of use thereof2024
Administration of nicotinamide mononucleotide in the treatment of disease2023
Administration of nicotinamide mononucleotide in the treatment of disease2023
Compositions and methods of treatment using nicotinamide mononucleotide2023
GDF15 in glaucoma and methods of use thereof2021
Administration of nicotinamide mononucleotide in the treatment of disease2021
Administration of nicotinamide mononucleotide in the treatment of disease2021
Administration of nicotinamide mononucleotide in the treatment of disease2019
Administration of nicotinamide mononucleotide in the treatment of disease2017
Administration of nicotinamide mononucleotide in the treatment of disease2017
Inhibition of choroidal neovascularization2016